chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness, swelling, and itching began on left deltoid region where the patient had received MCV4 #1 and 1 inch below that, HPV #3 on 10/18/12 (the day before).  On 10/20/12, pt was taken to the ER where it was determined to be an "allergic reaction" from vaccines rather than cellulitis.
My 13 year old daughter received the Gardasil vaccine. The reaction was almost immediate. Her eyes rolled up in her head and she began to shake violently. The vaccanation was over 24 hrs ago. She has been very weak and complains of headaches, blurred vision dizziness..etc. I was given no information about how long she will stay like this. Do I need to seek other medical help. This was extremely frightening and felt extremely unclear as to what will best help her.
Immediate but for 24 hrs only:  bad taste in mouth  elevated blood pressure/heart rate dizziness  lasted two days:  fever  muscle/joint pain  still continues:  insomnia
received / first dose / on 17Dec2019 / has not received the second dose yet; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The VAERS details for 1st dose were updated. The reporter consented to follow up.
Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Weakness-Medium
SHORTNESS OF BREATH- CURRENTLY ONGOING  Narrative:  Recommended employee go to PCP, urgent care, or ER today (4/20/21) for further evaluation and treatment if  needed.
Started with general aches, developed gradually into cough, hoarseness, soreness to injection site w/ whelped area at site, generalized light rash, low grade fever, generalized itching, watery eyes, then developed into SOB. That was on Wed, then progressed so by Monday, developed into Pneumonia, was off work for total of 5 days.
Initial report was received from a healthcare professional on 05 September 2012. A 65-year-old female patient received an intramuscular injection in the left deltoid of FLUZONE HIGH-DOSE, lot number U4491AA, on 04 September 2012. On 04 September 2012, the patient experienced hypotension, shortness of breath, myalgia, warm feeling in hands, fatigue and increased heart rate that persisted until 05 September 2012. The patient had a history of a shellfish allergy. The patient's outcome was reported as unknown. Documents held by sender: None.
I have had a mild tinnitus for approx last 8 years and after the 2nd shot and within 24 hours, the ringing has increased substantially.  The sound of TV no longer obscures it.  I despair that it will not dissipate and is permanent.  I reported this to the pharmacy and Dr.
Pt. here for lab work. Has red, painful upper (L) arm - hot. No evidence of abscess. Last tetanus in childhood. Advised ice pack. To RTC if not better in 3-5 days.
This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included nadolol (MANUFACTURER UNKNOWN) and hydrochlorothiazide, lisinopril (LISINOPRIL HCTZ). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient previously received  doxycycline and experienced allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 09:00, the patient experienced headache, nausea, vomiting, rapid heart rate and high blood pressure. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, nausea, vomiting, rapid heart rate and high blood pressure was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a 61 year old female patient, concerning herself. The patient's concurrent conditions were not reported; however, she did not have any drug reactions or allergies, and was not taking any concomitant medications. The patient's medical history included common cold sores. On 26-SEP-2017, the patient was vaccinated with a single dose of ZOSTAVAX in the left arm for prevention of shingles (dose, lot number and expiration date were not reported). On 28-SEP-2017, 2 days after getting the vaccine, the patient developed a cold sore (oral herpes). Additionally, on the same date, she experienced joint pain (arthralgia) and muscle hardness (myosclerosis) near the injection site. The patient did not seek for medical attention and no intervention to prevent serious criteria was performed. The outcome of oral herpes, arthralgia and myosclerosis was not reported. The reporter's causality assessment between all aforementioned events and ZOSTAVAX was not provided. Upon internal review myosclerosis, was considered to be medically significant.
I was absolutely fine after the injection, with only a slight soreness. A full week later, on the evening of  Friday , January 29, my arm felt extremely itchy at the injection site. When I removed my shirt, I saw that there was a large, symmetrical, slightly-raised red welt on my arm. It measured about 3 inches across in all directions, and was slightly warm to the touch. For the past three days I've noticed this area becoming flatter, and the rash seeming to spread and lighten. It has not been a major problem, aside from some continuing slight itchiness, but I worry that I might have additional problems when i get my second dose.
Woke up very sick, lost consciousness twice in the middle of the night in the bathroom and broke my nose
Fever. A physician reported that a pt received an injection of Flu Shield and within 6 hours, developed a fever which persisted for 7 days, and the pt was hospitalized. This is 1 of 2 reports from this facility of adverse events post vax of this Flu Shield lot.
11:30am shot 2:30pm overwhelming tired, Very dizzy and slept from 2:30-8pm Drank a little Gatorade and tried to rest.  At midnight I began with fever, Severe trembling, (more than just chills,) and violent vomiting for 6 to 8 hours. Headache, aches all over the body. I am on day two post vaccine, massive headache chills bodyaches diarrhea.
Extreme nausea, abdominal cramping, diarrhea, dizziness. Also headache and warm face (low fever) occurring for 2 hours , beginning 4 hours after vaccination.  Then  a little less severe for the following 2 hours. Then further diminishing over the next four  hours.  Felt OK  after 12 hours.
stomach cramps and throwing up; stomach cramps and throwing up; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events stomach cramps and throwing up,  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) stomach cramps and throwing up.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), stomach cramps and throwing up was unknown.
This spontaneous report as received from a pharmacist via a company representative refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX 23 (lot#, dose, route not reported). Concomitant medications were not provided. The pharmacist reported that on an unspecified date the patient experienced numbness in the arm and that his arm was "virtually unusable for about a day", after receiving PNEUMOVAX 23. The patient did not seek medical attention. Outcome of the event was unknown. Additional information has been requested.
This case was reported by a healthcare professional and described the occurrence of itching in a subject of unspecified age and gender who was vaccinated with influenza vaccine trivalent (Flulaval). On 15 September 2009 the subject received unspecified dose of Flulaval (unknown). On 15 September 2009, almost immediately after vaccination with Flulaval, the subject experienced itching.  The reporter stated that subject experienced itching from the inside out which began almost immediately after the shot was given. Specific information was not known. The reporter stated that the batch of vaccine for lot number AFLLA261AA might be defective which caused the adverse event. The reporter did not have specific information and is seeking advice on whether to continue giving injection with this lot.  The reporter did not have an expiration date. At the time of reporting the outcome of the events were unspecified. The reporter stated three additional subjects experienced adverse events; see cases A08/07879A, A0807882A and A0807884A. Follow up was received from 15 September 2009, via quality assurance (QA). QA stated this is an adverse event only and it will not be recorded as a complaint. Follow up was received on 18 September 2009 via sales representative, who reported the 40-year old female subject received Flulaval on 14 September 2009. The onset of itchiness (described as skin crawling) at injection site was immediate following injection; symptoms were not long lasting. Subject feeling well prior to vaccine, no fever, no other medications, no prior history of adverse events following flu vaccine. Subject was evaluated for rash and was negative. The events resolved on 14 September 2009 and was considered possibly related to Flulaval vaccination.
Redness, puffiness + warm to touch @ injection site above 30mm of redness. Site is tender to touch @ site of Varicella injection.
This non-serious spontaneous case, initially received on 19-Mar-2018, was reported by other health professional, concerning a 07-year-old child of unspecified gender. It was reported that, on an unspecified date, the temperature of the refrigerator in which vaccine was stored dropped to 32 F and was out of range for a total of 1 hour off and on for 2 weeks. On 01-Feb-2018, the patient was administered with FLUCELVAX QIV that was stored out of recommended temperature (route of administration: intramuscular, anatomical location: right deltoid, batch number: 195236, expiry date: 30-May-2018, dose: not reported). It was reported that, the patient did not experience any adverse event. Non-significant follow-up received on 07-May-2018: Upon internal review, it was realized that the expiry date was incorrect. Hence, the expiry date was changed from 31-May-2018 to 30-May-2018 in the product tab. The reporter confirmed that, the patient had no adverse reactions from the suspect vaccine that underwent temperature excursion. Narrative was amended accordingly.
Soreness at injection site.  Fever, chills, night sweats. Lymph node under left arm swollen.  Underarm body odor worse than normal.  Fatigue.
AN ITCHY RASH ACROSS POSTERIOR NECK; AN UNUSUAL REDNESS AND PEELING OF SKIN TO HANDS AND FEET. ON 9/10/15, A RAISED, ITCHY RASH APPEARED ON HANDS, ARMS AND WAS SPREADING TOWARDS BODY.
fever; chills; fatigue; nausea; aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (aches) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer vaccine (She received the Pfizer vaccine for her primary series (2 doses) with most recent dose just over 6 months ago.). Past adverse reactions to the above products included No adverse event with Pfizer vaccine.    On 30-Oct-2021 at 12:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Oct-2021, the patient experienced PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (aches). At the time of the report, PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (aches) outcome was unknown.            No Concomitant medications were reported. No Treatment information was reported.
Small bumps and blisters on upper back, under armpits, lower back, waistline and some lower legs
(R) Sc tissue hot to touch, reddenned. Antibiotics given/BENADRYL
Pt recvd 4 doses vax following 4th dose pt exp neck pain, back pain-top of head to waist generalized muscle ache; tingling to finger sx devel in 6 hrs & lasted 8 days; pt exp same rxn w/3rd dose; Pt still has joint pain;
Couldnt lift my right arm where Ireceived my shot. It is swollen andsore and hurts to move at all; Couldnt lift my right arm where Ireceived my shot. It is swollen andsore and hurts to move at all; Couldnt lift my right arm where Ireceived my shot. It is swollen andsore and hurts to move at all; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Pfizerer8727), via an unspecified route of administration in the right arm on 26Mar2021 at 18:30, as a single dose for COVID-19 immunisation. Medical history included grass allergy, allergy to cats and penicillin allergy (some penicillin-based medicines). Concomitant medications included isotretinoin (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN) and probiotic NOS (PROBIOTIC). The patient previously received doxycycline for an unknown indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Mar2021 at 07:30, the patient woke up in the morning after her shot, and she could not lift her right arm where she received her shot. It was swollen and sore and hurts to move at all. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events pain in right arm, swollen arm and pain upon movement were unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Significant tinnitus with abrupt onset 38 hours after vaccination. No resolution since.  The side effect Impacts my job as a cardiologist where I need my hearing for physical examination. I discussed the situation with Dr.  thereafter,  who recommended no further Pfizer vaccination in light of the time frame of the onset of new tinnitus related to vaccination.  He was the hospital epidemiologist Medical Center and is a board certified Infectious Disease consultant and Internal Medicine specialist.  He further recommended completion of my vaccination program with  the Jansen  COVID-19 vaccine and no booster.
HEADACHE; SORE ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, vaccinated on left deltoid, batch number: BA43LC, and expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination.  No concomitant medications were reported. On 19-MAR-2021, the subject experienced headache. On 19-MAR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache and sore arm was not reported. This report was non-serious.
Subsequently post vax, the pt developed nausea and vomiting. The reporter indicated that another pt experienced this event; however, he/she is not presently identifiable.
after I received the shot I was sick for 3 days, chills, nausea, upset stomach
Bilateral lower extremity weakness and new onset difficulty swallowing/eating, nausea and vomiting; loss rectal tone and diaphragm strength and mobility; respiratory failure requiring intubation; eventual death likely due to Acute Inflammatory Demyelinating Polyneuropathy (AIDP) most consistent with acute motor axonal neuropathy (AMAN) variant of Guillain-Barre Syndrome (GBS). Admitted patient. Transferred patient to ICU when requiring intubation and pressors and hydrocortisone for potential adrenal insufficiency. Gave broad-spectrum antibiotics and fluconazole for potential infectious causes of shock. Consulted Neurology for thorough workup including labs, imaging, and electromyogram and nerve conduction studies, Nephrology for CRRT and plasmapheresis, and Rheumatology and Dermatology for non-blanching macules on the abdomen. Myasthenia gravis unlikely given acetylcholine WNL and Lambert-Eaton less likely as muscle movements were fatigable with repetition. Infectious etiology less likely given negative viral panels. Gave high-dose thiamine and dexamethasone as well as 5 days of plasmapheresis with no improvement. Continued pressors for cardiovascular shock. Discussed moving onto IVIG therapy since no improvement with plasmapheresis and steroids. Family declined and opted for comfort care. Stopped her pressors and CRRT, and removed ET tube. Patient passed away.
Pericarditis; A spontaneous report was received from a nurse concerning a patient of unknown age and gender who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced pericarditis.  No medical history was provided.  No concomitant medications were reported.   On an unknown date, one hour before the onset of events, the patient received their first of two planned doses of mRNA-1273 (Batch number: nor provided) intramuscularly for the prophylaxis of COVID-19 infection.  An hour after vaccination, the patient had chest pain and "decided it was pericarditis" (medically significant).   No treatment information was provided.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event of pericarditis was unknown.   The reporter did not provide causality assessment for the event of pericarditis.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Patient wife states that patient was hospitalized with arrhythmia and fluid on the lungs.
Pt presented chief complaint of (L) arm/muscle pain that pt S&S is from flu shot. Pt first office visit was 11/28/11. Pain is worse with movement, and is sharp in quality, as well as a burning sensation. Pain was not relieved with anti-inflammatories, ice, or elevation.
Patient has a rash that started within 24hrs that appears to be Shingles. Fluid filled blisters in clusters.
Patient states that in the first two days after vaccination, she experienced flu-like symptoms. Her symptoms progressed and became more severe with nausea, vomiting, fever, and "sleeping legs" (numbness, tingling). Pt's mother called pharmacy on 6/3/2021 to express concern and pharmacist advised her to take daughter to emergency department. Follow-up calls to patient have gone unanswered.
Pt stepped on needle while at home. Left puncture wound to toe. Received DT at office. Numbness right arm, soreness in neck (back), shooting pains through right shoulder, headache, facial numbness, right jaw pain, lightheaded. Symptoms began one day after injection.
Pt presented to pharmacy for flu shot. Responded negative when questioned on precautions on consent form. About 30 min after vaccine, pt felt faint and lowered herself to knees.
I noticed that my thigh my right thigh about the size of my hand; when I stood up I could feel the pressure like there was some blockage and it hurt to walk; I noticed that my thigh my right thigh about the size of my hand; when I stood up I could feel the pressure like there was some blockage and it hurt to walk; It would get better and it hasn't got any better and it's getting red everyday it's getting darker red; This is a spontaneous report from a contactable consumer or other non-healthcare professional.  A 56-years-old male patient received first dose of bnt162b2 (BNT162B2, Pfizer BioNtech Covid-19 Vaccine), via an unspecified route of administration, administered in left arm on 18May2021 (Batch/Lot Number: EW0185) as single dose for covid-19 immunisation. Medical history included headache. Concomitant medications included ibuprofen (220mg) taken for headache. On 29May2021, the patient experienced i noticed that my thigh my right thigh about the size of my hand; when i stood up i could feel the pressure like there was some blockage and it hurt to walk and it would get better and it hasn't got any better and it's getting red everyday it's getting darker red. Clinical course of the event was reported as I was calling two weeks ago in one day, on 18May2021 I got my first Pfizer BioNtech shot vaccination shot and Saturday morning I noticed that my thigh my right thigh about the size of my hand I had something going on like, when I stood up I could feel the pressure like there was some blockage and it hurt to walk but as I kept walking it was slowly the pain would kind of subside, but I took some aspirin and anyway I waited several days to see if it would get better and it hasn't got any better and it's getting red everyday it's getting darker red, I don't have a health insurance I don't know if it's related to the shot or not but I was just wondering if it's anyway I would go to ER and if somebody could cover the costs that's why I was calling about. The patient took aspirin (200 mg) tablets two each and took two of those on Sunday took like three dosage. The patient further reported that the events have not improved, persisting. At the type of reporting, the outcome of the events i noticed that my thigh my right thigh about the size of my hand; when i stood up i could feel the pressure like there was some blockage and it hurt to walk and it would get better and it hasn't got any better and it's getting red everyday it's getting darker red was reported as unknown.
grandma states pt had a react to first series of vax; states pt had several periods of cyanosis; seen by MD in office; states MD advised to hold the pertussis w/next shots;
Flu vaccine was given with child sitting on her mother's lap with the intention that she sit there for several moments as she has fainted following a flu shot in the past.  After a few minutes, child was pale and sweaty.  Fanned her and gave her some water to drink.  After a couple of minutes, she passed out and was lowered to the floor without injury.  Child had 1 jerky movement of limbs and then opened her eyes and was awake.  Child was allowed to lie there for several moments and then was able to sit up.  After sitting up for several minutes, she felt like standing and did so without dizziness.